Botanical species · safety record

Arisaema erubescens

The EFSA Compendium of Botanicals holds 2 constituent measurements for Arisaema erubescens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Arisaema erubescens (Wall.) Schott

2Constituent measurements
0Safety records
2Cited sources
37Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 37 licensed products naming Arisaema erubescens as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Arisaema erubescens - Rhizome
  • Dried tuber
  • Finely powdered Arisaema crubescens (processed) with the bile of ox, sheep or pig
  • Powdered Arisaema erubescens with bile of ox or sheep
  • Rhizome
  • Root
  • Root mixed with bile of ox or sheep
  • Tuber

What the records describe

Constituents measured

  • Furan derivatives1
  • Lectins1

Plant parts

  • Roots and other underground parts1
  • Unspecified1

Preparations

  • Essential oil1
  • Fresh1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
LectinsRoots and other underground partsFreshHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Furan derivativesUnspecifiedEssential oil10 PercentGC-MSNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Liu, Xian Qiong., Wu, Hao., Yu, Hong Li., Zhao, Teng Fei., Pan, Yao Zong., Shi, Run Jun. Purification of a Lectin from Arisaema erubescens (Wall.) Schott and Its Pro-Inflammatory Effects. MOLECULES, 2011, vol. 16, no. 11, p. 9480-9494. DOI
  2. Yang, Nai-jia., Liu, Wen-wei., Huo, Xin., Gao, Yu-qiong., Liu, Jian-hua. Determination of chemical constituents of volatile oil from Arisaema erubescens.. Shengwu Jishu, 2007, vol. 17, no. 5, p. 52-54.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue